Hepatitis C

Showing NaN - NaN of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain Deficits in HIV/HCV Coinfected People Before and After

Completed
  • HIV
  • +2 more
  • Pegylated interferon alfa and ribavirin (PEG-IFN/RBV)
  • Lancaster, California
  • +3 more
May 11, 2016

Hepatitis C Trial in Worldwide (TMC435)

Completed
  • Hepatitis C
  • Bakersfield, California
  • +72 more
Mar 31, 2016

Hepatitis C Trial in United States (Daclatasvir, Sofosbuvir)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +36 more
Sep 24, 2015

Hepatitis C Trial in Worldwide (BI201335, PegIFN/RBV, Placebo)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +105 more
Aug 18, 2015

Hepatitis B, Hepatitis C, HIV Trial in Los Angeles (Parolee Comprehensive Care + Phone Coach, Parolee Brief HBV Program + Phone

Completed
  • Hepatitis B
  • +3 more
  • Parolee Comprehensive Care + Phone Coach
  • +2 more
  • Los Angeles, California
    Amistad de Los Angeles
May 26, 2015

Effects of Ribavirin on Zidovudine or Stavudine

Completed
  • HIV Infections
  • Hepatitis C
    • Los Angeles, California
    • +5 more
    May 15, 2015

    Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a)

    Terminated
    • Hepatitis C
    • Birmingham, Alabama
    • +58 more
    Mar 3, 2015

    Hepatitis C, HCV, Chronic Hepatitis C Infection Trial in United States (ABT-450, ABT-072, Ribavirin)

    Completed
    • Hepatitis C
    • +3 more
    • Los Angeles, California
    • +3 more
    Dec 29, 2014

    Chronic Hepatitis C Infection, Hepatitis C, Hepatitis C Virus Trial in United States (ABT-450, ABT-333, ribavirin)

    Completed
    • Chronic Hepatitis C Infection
    • +2 more
    • Los Angeles, California
    • +10 more
    Dec 29, 2014

    Hepatitis C, Human Immunodeficiency Virus Trial in Puerto Rico, United States (SOF, RBV)

    Completed
    • Hepatitis C
    • Human Immunodeficiency Virus
    • Birmingham, Alabama
    • +26 more
    Nov 14, 2014

    Hepatitis C Trial in Belgium, United States (ACH-0141625 (Sovaprevir), Placebo, Pegylated Interferon alpha-2a)

    Completed
    • Hepatitis C
    • ACH-0141625 (Sovaprevir)
    • +3 more
    • Los Angeles, California
    • +17 more
    Sep 8, 2014

    Safety in Subjects Who Participated inPhase 1 Study With

    Completed
    • Healthy
    • Hepatitis C
    • Los Angeles, California
    • +4 more
    Aug 13, 2014

    Hepatitis C Trial in Worldwide (biological, drug, other)

    Completed
    • Hepatitis C
    • Pegylated Interferon Alfa 2a
    • +3 more
    • Birmingham, Alabama
    • +115 more
    Jul 16, 2014

    Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated interferon alfa 2a)

    Completed
    • Hepatitis C
    • Birmingham, Alabama
    • +61 more
    Jul 9, 2014

    Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated Interferon Alfa 2a)

    Completed
    • Hepatitis C
    • Birmingham, Alabama
    • +52 more
    Jul 9, 2014

    Hepatitis C Trial in Worldwide (TMC435, Ribavirin (R), PegIFNa-2a (P))

    Completed
    • Hepatitis C
    • Los Angeles, California
    • +72 more
    May 19, 2014

    Hepatitis C Trial in Worldwide (Placebo, TMC435, Peginterferon alpha-2a or Peginterferon alpha-2b (PegIFNa-2a/b))

    Completed
    • Hepatitis C
    • Placebo
    • +3 more
    • Los Angeles, California
    • +61 more
    Jun 10, 2014

    Hepatitis C Trial in Worldwide (TMC435, Placebo, Peg-IFN-alfa-2a (P))

    Completed
    • Hepatitis C
    • La Jolla, California
    • +80 more
    May 30, 2014

    Hepatitis C Trial in Worldwide (Sofosbuvir, PEG, RBV)

    Completed
    • Hepatitis C
    • Birmingham, Alabama
    • +96 more
    Mar 4, 2014

    Subjects Previously Treated With Telaprevir

    Completed
    • Hepatitis C
    • Birmingham, Alabama
    • +40 more
    Feb 26, 2014

    Hepatitis C Trial in United States (LADR Treatment)

    Completed
    • Hepatitis C
    • LADR Treatment
    • Los Angeles, California
    • +7 more
    Apr 11, 2013